Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
05/25/2023 | Passage BIO, Inc. | PASG | Grant | Director Stock Option (Right to Buy) | 24k | $1.00 | $24k | | 05/25/2023 |
03/29/2023 | Harmony Biosciences Holdings, Inc. | | Payment of Exercise | | 15.4k | $33.36 | $514.2k | | 03/29/2023 |
03/29/2023 | Harmony Biosciences Holdings, Inc. | | Exercise | Restricted Stock Units | 30k | $0.00 | $0 | | 03/29/2023 |
12/01/2022 | Passage BIO, Inc. | PASG | Sale | Common Stock | 5k | $1.19 | $6k | | 12/01/2022 |
05/26/2022 | Passage BIO, Inc. | PASG | Grant | Director Stock Option (Right to Buy) | 24k | $1.76 | $42.2k | | 05/26/2022 |
05/27/2021 | Passage BIO, Inc. | PASG | Grant | Director Stock Option (Right to Buy) | 16.9k | $13.83 | $234k | | 05/27/2021 |
03/29/2021 | Harmony Biosciences Holdings, Inc. | | Grant | Restricted Stock Units | 60k | $0.00 | $0 | | 03/29/2021 |
03/29/2021 | Harmony Biosciences Holdings, Inc. | | Grant | Stock Option | 230k | $29.03 | $6.7M | | 03/29/2021 |
01/22/2021 | INTERCEPT PHARMACEUTICALS, INC. | ICPT | Grant | Common Stock | 17.2k | $0.00 | $0 | | 01/22/2021 |
01/22/2021 | INTERCEPT PHARMACEUTICALS, INC. | ICPT | Grant | Option to Purchase Common Stock | 26.9k | $29.46 | $792.5k | | 01/22/2021 |
01/05/2021 | INTERCEPT PHARMACEUTICALS, INC. | ICPT | Sale | Common Stock | 2.2k | $24.47 | $53.7k | | 12/31/2020 |
01/01/2021 | INTERCEPT PHARMACEUTICALS, INC. | ICPT | Payment of Exercise | Common Stock | 342 | $24.70 | $8.4k | | 12/31/2020 |
12/31/2020 | INTERCEPT PHARMACEUTICALS, INC. | ICPT | Payment of Exercise | Common Stock | 859 | $24.70 | $21.2k | | 12/31/2020 |
12/15/2020 | INTERCEPT PHARMACEUTICALS, INC. | ICPT | Sale | Common Stock | 1.8k | $32.78 | $57.8k | | 12/15/2020 |
10/01/2020 | INTERCEPT PHARMACEUTICALS, INC. | ICPT | Payment of Exercise | Common Stock | 296 | $42.08 | $12.5k | | 10/01/2020 |
07/01/2020 | INTERCEPT PHARMACEUTICALS, INC. | ICPT | Payment of Exercise | Common Stock | 615 | $46.52 | $28.6k | | 07/01/2020 |
04/01/2020 | INTERCEPT PHARMACEUTICALS, INC. | ICPT | Payment of Exercise | Common Stock | 615 | $58.40 | $35.9k | | 04/01/2020 |
03/03/2020 | Passage BIO, Inc. | PASG | Purchase | Common Stock | 5k | $18.00 | $90k | | 03/03/2020 |
02/27/2020 | Passage BIO, Inc. | PASG | Grant | Director Stock Option (Right to Buy) | 16.9k | $18.00 | $304.5k | | 02/27/2020 |
01/23/2020 | INTERCEPT PHARMACEUTICALS, INC. | ICPT | Grant | Common Stock | 5.6k | $0.00 | $0 | | 01/23/2020 |
01/23/2020 | INTERCEPT PHARMACEUTICALS, INC. | ICPT | Grant | Option to Purchase Common Stock | 9.2k | $99.66 | $916.9k | | 01/23/2020 |
01/01/2020 | INTERCEPT PHARMACEUTICALS, INC. | ICPT | Payment of Exercise | Common Stock | 669 | $123.92 | $82.9k | | 12/31/2019 |
12/31/2019 | INTERCEPT PHARMACEUTICALS, INC. | ICPT | Payment of Exercise | Common Stock | 551 | $123.92 | $68.3k | | 12/31/2019 |
10/01/2019 | INTERCEPT PHARMACEUTICALS, INC. | ICPT | Payment of Exercise | Common Stock | 626 | $65.87 | $41.2k | | 10/01/2019 |
07/01/2019 | INTERCEPT PHARMACEUTICALS, INC. | ICPT | Payment of Exercise | Common Stock | 615 | $79.17 | $48.7k | | 07/01/2019 |
04/01/2019 | INTERCEPT PHARMACEUTICALS, INC. | ICPT | Payment of Exercise | Common Stock | 615 | $111.50 | $68.6k | | 04/01/2019 |
01/16/2019 | INTERCEPT PHARMACEUTICALS, INC. | ICPT | Grant | Common Stock | 4.5k | $0.00 | $0 | | 01/16/2019 |
01/16/2019 | INTERCEPT PHARMACEUTICALS, INC. | ICPT | Grant | Option to Purchase Common Stock | 7.2k | $110.80 | $797.8k | | 01/16/2019 |
01/01/2019 | INTERCEPT PHARMACEUTICALS, INC. | ICPT | Payment of Exercise | Common Stock | 1.1k | $100.79 | $112.7k | | 01/01/2019 |
02/05/2018 | INTERCEPT PHARMACEUTICALS, INC. | ICPT | Grant | Common Stock | 6.9k | $0.00 | $0 | | 02/05/2018 |
02/05/2018 | INTERCEPT PHARMACEUTICALS, INC. | ICPT | Grant | Option to Purchase Common Stock | 10.5k | $58.74 | $616.8k | | 02/05/2018 |
02/01/2017 | INTERCEPT PHARMACEUTICALS, INC. | ICPT | Grant | Common Stock | 7k | $0.00 | $0 | | 02/01/2017 |
02/01/2017 | INTERCEPT PHARMACEUTICALS, INC. | ICPT | Grant | Option to Purchase Common Stock | 11.6k | $107.18 | $1.2M | | 02/01/2017 |